JP2025506473A5 - - Google Patents
Info
- Publication number
- JP2025506473A5 JP2025506473A5 JP2024547305A JP2024547305A JP2025506473A5 JP 2025506473 A5 JP2025506473 A5 JP 2025506473A5 JP 2024547305 A JP2024547305 A JP 2024547305A JP 2024547305 A JP2024547305 A JP 2024547305A JP 2025506473 A5 JP2025506473 A5 JP 2025506473A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- group
- substituted
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/075604 | 2022-02-09 | ||
| CN2022075604 | 2022-02-09 | ||
| PCT/CN2023/074936 WO2023151574A1 (en) | 2022-02-09 | 2023-02-08 | Heterocyclic glp-1 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506473A JP2025506473A (ja) | 2025-03-11 |
| JP2025506473A5 true JP2025506473A5 (https=) | 2026-02-17 |
Family
ID=87563618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547305A Pending JP2025506473A (ja) | 2022-02-09 | 2023-02-08 | ヘテロ環ｇｌｐ－１アゴニスト |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250177362A1 (https=) |
| EP (1) | EP4476216A4 (https=) |
| JP (1) | JP2025506473A (https=) |
| CN (1) | CN119343343A (https=) |
| WO (1) | WO2023151574A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202206429A (zh) | 2020-04-29 | 2022-02-16 | 美商迦舒布魯姆生物有限公司 | 雜環ｇｌｐ—１促效劑 |
| JP2023537501A (ja) | 2020-08-06 | 2023-09-01 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環ｇｌｐ－１アゴニスト |
| PT4408840T (pt) | 2021-09-27 | 2025-10-07 | Terns Pharmaceuticals Inc | Ácidos benzimidazolocarboxílicos como agonistas de glp-1r |
| CN118401519A (zh) | 2021-10-25 | 2024-07-26 | 拓臻制药公司 | 作为glp-1r激动剂的化合物 |
| CN119095843A (zh) | 2022-02-23 | 2024-12-06 | 拓臻制药公司 | 作为glp-1r激动剂的化合物 |
| EP4568664B1 (en) | 2023-04-07 | 2026-04-01 | Terns Pharmaceuticals, Inc. | Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity |
| CN120981457A (zh) | 2023-09-14 | 2025-11-18 | 歌礼制药(中国)有限公司 | Glp-1r激动剂及其治疗方法 |
| TW202521534A (zh) | 2023-11-24 | 2025-06-01 | 香港商歌禮製藥(中國)有限公司 | Glp-1r 激動劑及其治療方法 |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
| WO2025222008A1 (en) * | 2024-04-19 | 2025-10-23 | Eli Lilly And Company | Glucagon receptor agonists and their use as therapies |
| WO2025222000A1 (en) * | 2024-04-19 | 2025-10-23 | Eli Lilly And Company | Substituted 1,1'-biphenyl compounds as glucagon receptor agonists |
| WO2026078617A1 (en) * | 2024-10-11 | 2026-04-16 | Pfizer Inc. | Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190060A1 (ar) * | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
| KR102314286B1 (ko) * | 2016-12-16 | 2021-10-21 | 화이자 인코포레이티드 | Glp-1 수용체 작용제 및 이의 용도 |
| US10934279B2 (en) * | 2018-06-13 | 2021-03-02 | Pfizer Inc. | GLP-1 receptor agonists and uses thereof |
| JP2023537501A (ja) * | 2020-08-06 | 2023-09-01 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環ｇｌｐ－１アゴニスト |
| JP2025506474A (ja) * | 2022-02-09 | 2025-03-11 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環ｇｌｐ－１アゴニスト |
-
2023
- 2023-02-08 US US18/837,152 patent/US20250177362A1/en active Pending
- 2023-02-08 WO PCT/CN2023/074936 patent/WO2023151574A1/en not_active Ceased
- 2023-02-08 EP EP23752354.3A patent/EP4476216A4/en active Pending
- 2023-02-08 JP JP2024547305A patent/JP2025506473A/ja active Pending
- 2023-02-08 CN CN202380031897.1A patent/CN119343343A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025506473A5 (https=) | ||
| JP2023546055A5 (https=) | ||
| JP2023537501A5 (https=) | ||
| JP2023515404A5 (https=) | ||
| JP2025506474A5 (https=) | ||
| JP2023538949A5 (https=) | ||
| JP2025513071A5 (https=) | ||
| DE69622532T2 (de) | Glycoprotein iib/iiia-antagonisten | |
| JP2023540609A5 (https=) | ||
| JP2023513272A5 (https=) | ||
| BG108060A (bg) | Ацилирани 6,7,8,9-тетрахидро-5н- бензоциклохептениламини и използването им като фармацевтични средства | |
| JP2025509281A5 (https=) | ||
| JP2025510741A5 (https=) | ||
| JP2025504508A5 (https=) | ||
| TWI532731B (zh) | 新穎噠嗪酮及吡啶酮化合物 | |
| TWI691475B (zh) | Ｕｒａｔ１抑制劑 | |
| US11186590B2 (en) | Somatostatin modulators and uses thereof | |
| ZA200500026B (en) | 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydo-pyrido and 2,3-dihydro-2H-pyrroloÄ2,1-bÜ-quinazolinone derivatives. | |
| TW200911756A (en) | Novel compounds | |
| CN102223797A (zh) | 金刚烷基苯甲酰胺化合物 | |
| CN107207483A (zh) | α‑氨基‑β‑羧基粘康酸半醛脱羧酶抑制剂 | |
| JPWO2005115993A1 (ja) | キナゾリン誘導体 | |
| JP2020500838A (ja) | Α−アミノ−β−カルボキシムコン酸セミアルデヒドデカルボキシラーゼの阻害剤 | |
| JP4832897B2 (ja) | エステル誘導体及びその医薬用途 | |
| EP4163277A1 (en) | Novel pyrazole derivatives |